Birmingham, MI (PRWEB) October 30, 2012
Many people don’t know that there’s free medical treatment available at world class sites across America. For example, there are 4,967 breast cancer studies running in the U.S. and 400 of them are looking for thousands of patients right now. Anybody needing free 'cutting edge' breast cancer clinical trials can visit CureLauncher.com and instantly find a treatment site in their area. The “Clinical Trials” page on CureLauncher lists the breast cancer trials with a convenient map to show their location.
Only CureLauncher translates the complex, medical terminology into easy to understand English. It provides a simple Request Form to complete and a representative will follow-up with the next steps. A CureLauncher concierge person is also available to answer any questions. The information is free to all users and instantly helps people connect with clinical trials that can save their life.
"This MAGI Clinical Trials gathering represented medical treatment and hope for thousands of people suffering from disease and not knowing where to turn. We are proud to support their efforts to treat every person afflicted with breast cancer and other diseases”, said Founder and President, Stephen Goldner, JD, RAC. “CureLauncher.com is rapidly expanding its capabilities to help all people with illnesses find medical treatment, while helping NIH-caliber medical researchers generate funding for their research”.
Mr. Goldner’s seminar at the MAGI Conference on FDA clinical regulations for drugs and medical devices was based on his 40 years of experience getting FDA and worldwide approvals to make safer and more effective healthcare products. He is the Founder of Regulatory Affairs Associates, the FDA consultants to the National Institutes of Health in Bethesda MD.
It was discussed at the conference that of the 50,000 clinical trials that took place in the U.S. in 2009, 80 percent were delayed by at least a month due to low enrollment. Mr. Goldner’s regulatory expertise and credibility make CureLauncher the preferred source to connect people with clinical trials. “CureLauncher addresses the current need to provide easy access for people to find clinical trials, while also providing reliable referrals to the trial sites of patients that will benefit”, said Vice President David Fuehrer.
To learn more, visit http://www.curelauncher.com
CureLauncher is the only crowdfunding platform dedicated to funding NIH-caliber drug and medical device research. It is an online community where people can find and fund medical research in a way never before possible. Advocates of the research interact with each other and leading medical professionals to generate support. CureLauncher puts funding back into drug and medical device research.